Skip to main content

Table 2 Quantitative and qualitative variables collected at 6 (M6), 12 (M12), 18 (M18) and 24 (M24) months after alcohol withdrawal

From: A prospective hospital study of alcohol use disorders, comorbid psychiatric conditions and withdrawal prognosis

  M6 M12 M18 M24
Mean ± SD or  % N Mean ± SD or  % N Mean ± SD or  % N Mean ± SD or  % N
With any data 51.8 171 38.6 146 42.7 141 51.8 249
With data to assess abstinence 27.6 91 33.9 112 33.9 112 75.5 171
Abstinent 57.1 52 40.2 45 46.4 52 41.4 103
Reasons for the absence of follow-up
 No data—lost 47.8 76 62.4 118 38.8 128 13.3 13
 Impossible to come 24.8 82 34.4 65 15.2 50 19.4 64
 Death 0.03 1 3.2 6 7.3 14 21.4 21
With a psychiatric comorbidity  56.7 97  63.7 93  42.5 77  48.2 120
Type of psychiatric comorbidity      37.7    
 None 29.9 29 42.0 39 5.19 29 46.7 50
 Dementia 0 0 0 0 15.5 4 0 0
 Psychosis 9.3 9 18.2 17 20.7 12 14.9 16
 Mood disorder 37.1 36 20.4 19 3.9 16 13.1 14
 Anxiety disorder 9.3 9 3.2 3 24.7 3 1.9 2
 Personality disorder 21 18 20.4 19   19 15.9 17
With somatic comorbidity 11.3 11 6.5 6 5.2 4 5.6 6
Global Assessment of Functioning 59.9 ± 19.7 70 56.7 ± 20.1 66 59.7 ± 20.6 63 58.2 ± 19.3 88
AUDIT score   14.5 ± 12.2 130   14.0 ± 12.1 162
 Risk use (score ≤7)   36.2 45   40.1 65
 Harmful use (7 < score <13)   13.1 17   6.2 10
 Dependence (score ≥13)   50.8 66   50.6 82
BDI 8.3 ± 7.3 163 7.8 ± 7.5 133 7.2 ± 7.1 130 7.7 ± 7.3 168
 Absent 29.5 48 39.1 52 36.9 48 40.2 68
 Slight 25.8 42 15.8 21 24.6 32 20.1 34
 Moderate 28.8 47 30.1 40 25.4 33 21.3 36
 Severe 15.9 26 15.0 20 13.1 17 18.3 31
MCV (UI/L) 94.9 ± 6.0 175 95.4 ± 5.9 140 94.4 ± 5.9 141 94.3 ± 6.2 169
 % >normal values (n) 34.9 61 40 56 30.5 43 34.3 58
TGO (UI/L)     39.0 ± 55.3  
 % >normal values (n)        24.6 41
TGP (UI/L)     38.8 ± 61.9  
 % >normal values (n)        29.9 50
GGT (UI/L) 94.9 ± 6.0 175 108.0 ± 269.3 143 112.9 ± 290.8 140 156.0 ± 379.9 168
 % >normal values (n) 43.4 76 40.6 58 41.4 58 18.8 82
Current psychotropic treatment         
 Neuroleptics 15.3 27 13.3 20 18.0 27 15.0 36
 Atypical antipsychotics 25.0 44 24.6 37 24.0 36 23.0 55
 Thymoregulators 13.6 24 12.0 18 12.0 18 11.3 27
 Antidepressants 63.0) 111 65.3 98 62.6 94 51.8 124
 Anxiolytics 67.0 118 65.3 98 61.3 92 57.3 137
 Benzodiazepines 56.2 99 56.0 84 11.5 38 48.9 116
 Related to benzodiazepines 22.1 39 17.3 26 25.1 83 18.1 43
  1. AUDIT Alcohol Use Disorder Identification Test, BDI Beck Depression Inventory, GGT gamma-glutamyl transferase, MCV mean corpuscular volume, SGOT serum glutamate oxaloacetate transaminase, SGPT serum glutamic pyruvic transaminase